Prevalence of obstructive sleep apnoea in acute coronary syndrome patients: systematic review and meta-analysis

• Published in: BMC cardiovascular disorders 2020-03, Vol.20 (1), p.147-147, Article 147
• Main Authors: Le Grande, Michael R, Beauchamp, Alison, Driscoll, Andrea, Jackson, Alun C
• Format: Article
• Language: English
• Subjects: Acute coronary syndrome; Acute coronary syndromes; Apnea; Bibliographic data bases; Cardiac patients; Cardiovascular disease; Cardiovascular diseases; Cardiovascular research; Care and treatment; Complications and side effects; Coronary heart disease; Development and progression; Diseases; Estimates; Heart attacks; Heart failure; Hospital admission and discharge; Hypertension; Medical care quality; Meta-analysis; Methods; Obstructive sleep apnoea; Patients; Population; Prevalence; Rehabilitation; Risk factors; Sleep; Sleep apnea; Sleep assessment; Sleep disorders; Studies; Surgery; Systematic review; Time
• ISSN: 1471-2261; 1471-2261
• DOI: 10.1186/s12872-020-01430-3

Obstructive Sleep Apnoea (OSA) has been recognised as a risk factor for cardiovascular diseases such as hypertension and cardiovascular events such as acute coronary syndrome (ACS). Since it is also known to reduce exercise tolerance, it is important to establish the prevalence of OSA in ACS patients, particularly in those who are commencing cardiac rehabilitation (CR) programs. Using PRISMA guidelines a systematic search was conducted in order to identify studies that objectively measured (using polysomnography or portable monitoring) the prevalence of OSA in ACS patients following hospital admission. A data extraction table was used to summarise study characteristics and the quality of studies were independently assessed using the Joanna Briggs Institute Prevalence Critical Appraisal Tool. Meta-analysis of the selected studies was conducted in order to estimate OSA prevalence as a function of the two main methods of measurement, the severity of OSA, and timing of the OSA assessment following ACS hospital admission. Pooled prevalence estimates of OSA using the "gold standard" polysomnography ranged from 22% for severe OSA to 70% for mild OSA, at any time after hospital admission. Similar prevalence estimates were obtained using portable monitoring, but interpretation of these results are limited by the significant heterogeneity observed among these studies. Prevalence of OSA following ACS is high and likely to be problematic upon patient entry into CR programs. Routine screening for OSA upon program entry may be necessary to optimise effectiveness of CR for these patients.